Results 71 to 80 of about 46,872 (291)

Experimental models of coronary artery restenosis

Journal of the American College of Cardiology, 1992
The study of potentially effective drug therapies and mechanical devices for the prevention of restenosis after percutaneous coronary revascularization has relied heavily on the use of experimental animal models. To date, greater than 50 experimental studies have been reported and have suggested that at least nine different classes of pharmacologic ...
David W.M. Muller, Stephen G. Ellis, Eric J. Topol   +2 more
openaire   +3 more sources

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions

Кардиоваскулярная терапия и профилактика, 2007
Coronary restenosis remains the main problem for effectiveness of percutaneous transluminal coronary angioplasty (PCA) and coronary stenting (CS). The aim of this review is to analyze pathogenetic mechanisms of coronary restenosis after PCA and CS, as ...
Yu. A. Shuvalova, A. N. Meshkov, A. I. Kaminny, G. F. Piksina, V. V. Kukharchuk   +4 more
doaj  

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)

Cells, 2022
Coronary stents are among the most common therapies worldwide. Despite significant improvements in the biocompatibility of these devices throughout the last decades, they are prone, in as many as 10–20% of cases, to short- or long-term failure.
Tommaso Gori
doaj   +1 more source

Future of smart cardiovascular implants [PDF]

, 2018
Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav, Mercer, John R., Neale, Steven   +2 more
core   +1 more source

Effects of balloon injury on neointimal hyperplasia in steptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. [PDF]

, 2001
BACKGROUND: The mechanisms of increased neointimal hyperplasia after coronary interventions in diabetic patients are still unknown. METHODS AND RESULTS: Glucose and insulin effects on in vitro vascular smooth muscle cell (VSMC) proliferation and ...
Carriero M.V., Cavuto L., Chiariello M., Chieffo A., Coppola C., Davalli A.M., Di Lorenzo E., ESPOSITO, GIOVANNI, Indolfi C., Pardo F., PERRINO, CINZIA, RAPACCIUOLO, ANTONIO, STABILE, EUGENIO, Torella D.   +13 more
core  

Role of noncoding RNA in vascular remodelling [PDF]

, 2016
Purpose of review: Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are becoming fundamentally important in the pathophysiology relating to injury-induced vascular remodelling.
Baker, Andrew H., Bradshaw, Angela C., Deng, Lin   +2 more
core   +1 more source

Restenosis after coronary angioplasty: An overview

Journal of the American College of Cardiology, 1991
Despite substantial basic and clinical efforts to address the problem of restenosis after percutaneous coronary intervention, effective preventive therapies have not yet been developed. Nevertheless, the accumulated information has provided much insight into the process of restenosis in addition to allowing standards to be developed for adequate ...
Robert M. Califf, James E. Tcheng, Donald F. Fortin, William R. Harlan, Richard S. Stack, Charlotte L. Nelson, Daniel B. Mark, David J. Frid, James R. Bengtson, E. Magnus Ohman   +9 more
openaire   +2 more sources

Fractional Flow Reserve Directed Percutaneous Coronary Intervention Optimization Using High‐Definition Intravascular Ultrasound in Non‐ST‐Segment Elevation Acute Coronary Syndrome Versus Chronic Coronary Syndrome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular ultrasound (IVUS)‐guided optimization of suboptimal fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) results in a significant increase in both post‐PCI FFR and minimal lumen and stent areas (MLA and MSA, respectively).
Frederik T. W. Groenland, Tara Neleman, Annemieke C. Ziedses des Plantes, Alessandra Scoccia, Isabella Kardys, Wijnand K. den Dekker, Jeroen M. Wilschut, Roberto Diletti, Nicolas M. Van Mieghem, Joost Daemen   +9 more
wiley   +1 more source

Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?

International Journal of Preventive Medicine, 2011
Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and hypertension are the known risk factors for coronary artery diseases; however, their role is unknown in restenosis after coronary stenting.
Alireza Khosravi, Masoud Pourmoghaddas, Fereshteh Ziaie, Arezoo Enteshari, Arsalan Khaledifa, Ahmad Bahonar   +5 more
doaj  

Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies

Cardiovascular Therapeutics, 2020
Aim. The marked variation in bifurcation anatomy has brought about an ongoing search for stents specifically constructed for coronary bifurcations.
Robert J. Gil, Jacek Bil, Adam Kern, Luis A. Iñigo-Garcia, Radoslaw Formuszewicz, Slawomir Dobrzycki, Dobrin Vassilev, Roxana Mehran   +7 more
doaj   +1 more source